<p>/PRNewswire/ -- R3 Continuum 今天宣布扩大其高级临床领导团队，任命 <strong>David Wright, Psy.D. 为临床战略高级副总裁</strong>，以及 <strong>Maria Whitter, MSW, LCSW, CEAP, SAP 为临床服务副总裁</strong>。这些任命强调了 R3 在临床卓越、创新和可扩展增长方面的持续投资，因为对高影响力的工作场所行为健康解决方案的需求持续加速。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>David Wright</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Maria Whitter</p>
<p>在他的角色中，Wright 博士将领导 R3 的临床市场战略，指导差异化服务模型的开发，并作为雇主、经纪人、顾问和行业合作伙伴的主要临床声音。他在工作场所行为健康战略、企业项目领导和市场创新方面拥有超过二十年的经验，包括在 Headspace、meQuilibrium 和 Anthem 的高级领导角色。Wright 博士因将临床深度与商业洞察相结合而广受尊重，他将在加强 R3 的市场领导地位和增长轨迹方面发挥关键作用。</p>
<p>Whitter 将监督企业临床运营，推进 R3 的临床交付战略，加强基于数据的质量监督，并确保 R3 在全国范围内提供一致的高质量护理。她在临床运营、工作场所健康、合规、危机响应和项目创新方面拥有超过 20 年的行为健康领导经验，曾在 Optum、Centene 和 Magellan Health 担任领导职务。Whitter 以建立高绩效团队和可扩展的基于证据的项目而闻名，她将专注于将卓越落实为 R3 继续扩展。</p>
<p>Wright 和 Whitter 将在运营、数据、技术、战略和客户团队之间紧密合作，以确保 R3 提供可衡量的成果、临床可信度和差异化的价值。</p>
<p>&#34;随着 R3 的持续增长，我们的领导结构必须与我们的雄心相适应，&#34; R3 Continuum 首席执行官 Scott T. Alfieri 说。&#34;David 和 Maria 带来了互补的优势，深化了我们的临床基础，同时为下一阶段的增长做好准备。这些任命反映了我们对扩大卓越、增强市场影响力的承诺，并确保 R3 继续成为雇主在工作场所行为健康方面信赖的合作伙伴。&#34;</p>
<p><strong>关于 R3 Continuum</strong></p>
<p>R3 Continuum 是专业工作场所行为健康解决方案的领导者，帮助组织增强韧性、提升绩效，并支持员工的心理健康。R3 以临床卓越为基础，致力于可衡量的影响，在正确的时刻提供正确的支持——帮助个人、团队和组织蓬勃发展，同时实现有意义的商业成果。</p>
<p>来源 R3 Continuum</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI5Jk5ld3NJdGVtSWQ9Q0c0NTgxOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjkwODE1UFJfTkVXU19VU1BSX19fX19DRzQ1ODE4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI5Jk5ld3NJdGVtSWQ9Q0c0NTgxOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjkwODE1UFJfTkVXU19VU1BSX19fX19DRzQ1ODE4"/></p>

<p>R3 Continuum 扩大了其高级临床领导团队，任命 David Wright, Psy.D. 为临床战略高级副总裁，Maria Whitter, MSW, LCSW, CEAP, SAP 为临床服务副总裁。这些任命旨在提升临床卓越性，并支持日益增长的职场行为健康解决方案需求。Wright 博士将负责临床市场战略，而 Whitter 将监督临床运营，确保 R3 在全国范围内提供高质量的护理。首席执行官 Scott T. Alfieri 强调了发展领导力以增强市场影响力和支持 R3 增长的重要性</p>

<p>, /PRNewswire/ -- R3 Continuum today announced the expansion of its senior clinical leadership team with the appointments of <strong>David Wright, Psy.D., as Senior Vice President of Clinical Strategy</strong>, and <strong>Maria Whitter, MSW, LCSW, CEAP, SAP, as Vice President of Clinical Services</strong>. These appointments underscore R3's continued investment in clinical excellence, innovation, and scalable growth as demand for high-impact workplace behavioral health solutions continues to accelerate.</p>
<div class="lb-trans"><p>/PRNewswire/ -- R3 Continuum 今天宣布扩大其高级临床领导团队，任命 <strong>David Wright, Psy.D. 为临床战略高级副总裁</strong>，以及 <strong>Maria Whitter, MSW, LCSW, CEAP, SAP 为临床服务副总裁</strong>。这些任命强调了 R3 在临床卓越、创新和可扩展增长方面的持续投资，因为对高影响力的工作场所行为健康解决方案的需求持续加速。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>David Wright</p>
<div class="lb-trans"><p>David Wright</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Maria Whitter</p>
<div class="lb-trans"><p>Maria Whitter</p>
</div><p>In his role, Dr. Wright will lead R3's clinical market strategy, guide the development of differentiated service models, and serve as a primary clinical voice to employers, brokers, consultants, and industry partners. He brings more than two decades of experience spanning workplace behavioral health strategy, enterprise program leadership, and market-facing innovation, including senior leadership roles at Headspace, meQuilibrium, and Anthem. Widely respected for blending clinical depth with commercial insight, Dr. Wright will play a key role in strengthening R3's market leadership and growth trajectory.</p>
<div class="lb-trans"><p>在他的角色中，Wright 博士将领导 R3 的临床市场战略，指导差异化服务模型的开发，并作为雇主、经纪人、顾问和行业合作伙伴的主要临床声音。他在工作场所行为健康战略、企业项目领导和市场创新方面拥有超过二十年的经验，包括在 Headspace、meQuilibrium 和 Anthem 的高级领导角色。Wright 博士因将临床深度与商业洞察相结合而广受尊重，他将在加强 R3 的市场领导地位和增长轨迹方面发挥关键作用。</p>
</div><p>Whitter will oversee enterprise clinical operations, advance R3's clinical delivery strategy, strengthen data-informed quality oversight, and ensure consistent, high-quality care across R3's national footprint. She brings more than 20 years of behavioral health leadership experience across clinical operations, workplace wellbeing, regulatory compliance, crisis response, and program innovation, with prior leadership roles at Optum, Centene, and Magellan Health. Known for building high-performing teams and scalable, evidence-based programs, Whitter will focus on operationalizing excellence as R3 continues to expand.</p>
<div class="lb-trans"><p>Whitter 将监督企业临床运营，推进 R3 的临床交付战略，加强基于数据的质量监督，并确保 R3 在全国范围内提供一致的高质量护理。她在临床运营、工作场所健康、合规、危机响应和项目创新方面拥有超过 20 年的行为健康领导经验，曾在 Optum、Centene 和 Magellan Health 担任领导职务。Whitter 以建立高绩效团队和可扩展的基于证据的项目而闻名，她将专注于将卓越落实为 R3 继续扩展。</p>
</div><p>Together, Wright and Whitter will partner closely across operations, data, technology, strategy, and client teams to ensure R3 delivers measurable outcomes, clinical credibility, and differentiated value at scale.</p>
<div class="lb-trans"><p>Wright 和 Whitter 将在运营、数据、技术、战略和客户团队之间紧密合作，以确保 R3 提供可衡量的成果、临床可信度和差异化的价值。</p>
</div><p>&#34;As R3 continues to grow, it's critical that our leadership structure evolves alongside our ambition,&#34; said Scott T. Alfieri, Chief Executive Officer of R3 Continuum. &#34;David and Maria bring complementary strengths that deepen our clinical foundation while positioning us for the next phase of growth. These appointments reflect our commitment to scaling excellence, strengthening our market impact, and ensuring R3 remains the trusted partner employers rely on for workplace behavioral health.&#34;</p>
<div class="lb-trans"><p>&#34;随着 R3 的持续增长，我们的领导结构必须与我们的雄心相适应，&#34; R3 Continuum 首席执行官 Scott T. Alfieri 说。&#34;David 和 Maria 带来了互补的优势，深化了我们的临床基础，同时为下一阶段的增长做好准备。这些任命反映了我们对扩大卓越、增强市场影响力的承诺，并确保 R3 继续成为雇主在工作场所行为健康方面信赖的合作伙伴。&#34;</p>
</div><p><strong>About R3 Continuum</strong></p>
<div class="lb-trans"><p><strong>关于 R3 Continuum</strong></p>
</div><p>R3 Continuum is the leader in specialty workplace behavioral health solutions, helping organizations strengthen resilience, elevate performance, and support the mental wellbeing of their people. Grounded in clinical excellence and driven by measurable impact, R3 delivers the right support at the right moment—helping individuals, teams, and organizations thrive while achieving meaningful business outcomes.</p>
<div class="lb-trans"><p>R3 Continuum 是专业工作场所行为健康解决方案的领导者，帮助组织增强韧性、提升绩效，并支持员工的心理健康。R3 以临床卓越为基础，致力于可衡量的影响，在正确的时刻提供正确的支持——帮助个人、团队和组织蓬勃发展，同时实现有意义的商业成果。</p>
</div><p>SOURCE R3 Continuum</p>
<div class="lb-trans"><p>来源 R3 Continuum</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDI5Jk5ld3NJdGVtSWQ9Q0c0NTgxOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjkwODE1UFJfTkVXU19VU1BSX19fX19DRzQ1ODE4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG45818&amp;Transmission_Id=202604290815PR_NEWS_USPR_____CG45818&amp;DateId=20260429"/></p>

ETR3 Continuum 扩大临床领导团队以加速公司增长和市场影响力